Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026
Quanterix Corp QTRX
$3.27
▲ +2.83%
(+$0.09)
Open
$3.23
Prev Close
$3.18
Day Range
$3.11 – $3.29
52W Range
$2.15 – $8.77
Market Cap
$154.65M
Beta
1.04
EPS (TTM)
$-2.63
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-12-07 |
| Shares Out. | 47,110,000 |
| Website | quanterix.com/ ↗ |
| Phone | 13026587581 |
| Employees | 450 |
| Revenue | $32.9M |
| Gross Profit | $12.7M |
| Net Income | -$48.9M |
| Free Cash Flow | -$81.7M |
| Total Assets | $319.6M |
| Total Liabilities | $82.4M |
| Equity | $237.2M |
About Quanterix Corp
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
Quanterix Corp is a publicly traded company under the ticker symbol QTRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-09-01)